Eagle Pharmaceuticals Gross Margin 2013-2023 | EGRX
Current and historical gross margin for Eagle Pharmaceuticals (EGRX) over the last 10 years. The current gross profit margin for Eagle Pharmaceuticals as of June 30, 2023 is %.
| Eagle Pharmaceuticals Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-06-30 | $0.26B | $0.18B | 69.77% |
| 2023-03-31 | $0.27B | $0.18B | 68.16% |
| 2022-12-31 | $0.32B | $0.22B | 69.72% |
| 2022-09-30 | $0.30B | $0.21B | 70.47% |
| 2022-06-30 | $0.27B | $0.20B | 73.53% |
| 2022-03-31 | $0.25B | $0.19B | 76.02% |
| 2021-12-31 | $0.17B | $0.13B | 75.44% |
| 2021-09-30 | $0.18B | $0.14B | 75.98% |
| 2021-06-30 | $0.19B | $0.14B | 75.13% |
| 2021-03-31 | $0.18B | $0.13B | 73.22% |
| 2020-12-31 | $0.19B | $0.14B | 75.53% |
| 2020-09-30 | $0.19B | $0.14B | 76.34% |
| 2020-06-30 | $0.18B | $0.13B | 73.45% |
| 2020-03-31 | $0.19B | $0.14B | 70.83% |
| 2019-12-31 | $0.20B | $0.14B | 68.88% |
| 2019-09-30 | $0.20B | $0.14B | 66.18% |
| 2019-06-30 | $0.21B | $0.15B | 68.69% |
| 2019-03-31 | $0.22B | $0.15B | 70.83% |
| 2018-12-31 | $0.21B | $0.15B | 70.89% |
| 2018-09-30 | $0.20B | $0.15B | 72.06% |
| 2018-06-30 | $0.22B | $0.16B | 74.07% |
| 2018-03-31 | $0.21B | $0.16B | 74.88% |
| 2017-12-31 | $0.24B | $0.18B | 75.53% |
| 2017-09-30 | $0.27B | $0.21B | 76.75% |
| 2017-06-30 | $0.25B | $0.18B | 74.80% |
| 2017-03-31 | $0.24B | $0.18B | 74.68% |
| 2016-12-31 | $0.19B | $0.13B | 70.00% |
| 2016-09-30 | $0.13B | $0.09B | 68.50% |
| 2016-06-30 | $0.10B | $0.06B | 65.26% |
| 2016-03-31 | $0.06B | $0.04B | 60.00% |
| 2015-12-31 | $0.07B | $0.05B | 77.27% |
| 2015-09-30 | $0.05B | $0.04B | 66.67% |
| 2015-06-30 | $0.05B | $0.04B | 68.63% |
| 2015-03-31 | $0.05B | $0.04B | 70.59% |
| 2014-12-31 | $0.02B | $0.01B | 40.00% |
| 2014-09-30 | $0.02B | $0.01B | 42.11% |
| 2014-06-30 | $0.02B | $0.01B | 57.14% |
| 2014-03-31 | $0.02B | $0.01B | 50.00% |
| 2013-12-31 | $0.02B | $0.01B | 52.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.317B |
| Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $201.960B | 25.76 |
| Stryker (SYK) | United States | $147.572B | 33.26 |
| Boston Scientific (BSX) | United States | $130.758B | 37.59 |
| Medtronic (MDT) | Ireland | $113.242B | 16.85 |
| EssilorLuxottica (ESLOY) | France | $110.003B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.726B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.008B | 27.29 |
| GE HealthCare Technologies (GEHC) | United States | $38.798B | 20.12 |
| ResMed (RMD) | United States | $36.289B | 29.82 |
| Terumo (TRUMY) | Japan | $29.859B | 42.17 |
| Koninklijke Philips (PHG) | Netherlands | $24.401B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.886B | 13.93 |
| Insulet (PODD) | United States | $19.297B | 76.84 |
| Baxter (BAX) | United States | $17.259B | 11.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.746B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.206B | 34.68 |
| BellRing Brands (BRBR) | United States | $9.277B | 39.22 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.920B | 13.76 |
| TG Therapeutics (TGTX) | United States | $4.812B | 0.00 |
| Haemonetics (HAE) | United States | $4.690B | 22.89 |
| ICU Medical (ICUI) | United States | $4.348B | 41.49 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 20.06 |
| Perrigo (PRGO) | Ireland | $3.598B | 10.59 |
| Envista Holdings (NVST) | United States | $3.531B | 26.31 |
| Agios Pharmaceuticals (AGIO) | United States | $3.366B | 0.00 |
| Neogen (NEOG) | United States | $3.324B | 38.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.961B | 18.99 |
| QuidelOrtho (QDEL) | United States | $2.767B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $2.322B | 56.43 |
| Warby Parker (WRBY) | United States | $2.158B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.894B | 33.15 |
| AtriCure (ATRC) | United States | $1.786B | 0.00 |
| InMode (INMD) | Israel | $1.618B | 9.73 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.438B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 10.28 |
| Curaleaf Holdings (CURLF) | Canada | $1.326B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.223B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.015B | 17.90 |
| Owens & Minor (OMI) | United States | $0.997B | 7.79 |
| CeriBell (CBLL) | United States | $0.981B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.889B | 29.71 |
| Capricor Therapeutics (CAPR) | United States | $0.822B | 0.00 |
| Evolus (EOLS) | United States | $0.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.678B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.615B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.585B | 17.67 |
| Quanterix (QTRX) | United States | $0.582B | 0.00 |
| Surmodics (SRDX) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.389B | 0.00 |
| ZimVie (ZIMV) | United States | $0.389B | 32.74 |
| Canopy Growth (CGC) | Canada | $0.370B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.366B | 34.81 |
| Cerus (CERS) | United States | $0.351B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.309B | 20.70 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| Biote (BTMD) | United States | $0.299B | 6.57 |
| Zynex (ZYXI) | United States | $0.273B | 57.13 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Omeros (OMER) | United States | $0.247B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 16.01 |
| Jin Medical (ZJYL) | China | $0.223B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 89.67 |
| Organigram Holdings (OGI) | Canada | $0.173B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 97.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.96 |
| Zevia PBC (ZVIA) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 11.03 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Rockwell Medical (RMTI) | United States | $0.088B | 47.17 |
| Cellectar Biosciences (CLRB) | United States | $0.087B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.69 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| MariMed (MRMD) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.046B | 0.00 |
| ImmuCell (ICCC) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.60 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |